Professional
Added to YB: 2026-06-19
Pitch date: 2026-03-31
AZN [bullish]
AstraZeneca PLC
-17.83%
current return
Author Info
No bio for this author
Company Info
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
Market Cap
GBP 254.1B
Pitch Price
GBP 147.92
Price Target
N/A
Dividend
1.97%
EV/EBITDA
13.87
P/E
24.53
EV/Sales
4.59
Sector
Pharmaceuticals
Category
growth
Polen International Growth New Postion: AstraZeneca PLC
AZN (new position): UK biopharma transformed post-2010s patent cliffs into diversified portfolio across oncology, rare diseases, cardiovascular, renal/metabolic, respiratory/immunology. Strong oncology pipeline incl ADCs, plus obesity/hypertension drugs. Expect low double-digit shareholder returns through 2030.
Read full article (1 min)